Visa reported better-than-expected earnings Wednesday — and one “Fast Money” trader said the results were foreshadowed if you knew where to look. Read More
Considering Illumina just adopted a poison pill defense strategy, you might think a deal with Roche is out of the question. But Karen Finerman says it's not. Read More